Form DEF 14A CBRE GROUP, INC. For: May 21
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260403/AE2LL22DZZ2RP2Z2229N2MYRI5GSZZ22D282
Filed on: April 3, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on CBRE Group (CBRE) as AI Proves to Be a Tailwind
- Tangem Integrates Mercuryo's Native Apple Pay, Bringing One-Tap Crypto Purchases to Self-Custody
- Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
